228 related articles for article (PubMed ID: 34836270)
1. Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria.
Scala I; Concolino D; Nastasi A; Esposito G; Crisci D; Sestito S; Ferraro S; Albano L; Ruoppolo M; Parenti G; Strisciuglio P
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836270
[TBL] [Abstract][Full Text] [Related]
2. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
3. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
4. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria.
Porta F; Giorda S; Ponzone A; Spada M
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1519-1523. PubMed ID: 33581706
[TBL] [Abstract][Full Text] [Related]
7. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
[TBL] [Abstract][Full Text] [Related]
8. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
Yano S; Moseley K; Fu X; Azen C
PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
[TBL] [Abstract][Full Text] [Related]
10. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
11. The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult
van Vliet D; van der Goot E; van Ginkel WG; van Faassen MHJR; de Blaauw P; Kema IP; Martinez A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31546852
[TBL] [Abstract][Full Text] [Related]
12. Large neutral amino acids in daily practice.
Ahring KK
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S187-90. PubMed ID: 20300852
[TBL] [Abstract][Full Text] [Related]
13. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
Moats RA; Moseley KD; Koch R; Nelson M
Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
[TBL] [Abstract][Full Text] [Related]
14. Advances in the nutritional and pharmacological management of phenylketonuria.
Ney DM; Blank RD; Hansen KE
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
[TBL] [Abstract][Full Text] [Related]
15. Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.
van Spronsen FJ; Smit PG; Koch R
J Inherit Metab Dis; 2001 Feb; 24(1):1-4. PubMed ID: 11286377
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids.
Concolino D; Mascaro I; Moricca MT; Bonapace G; Matalon K; Trapasso J; Radhakrishnan G; Ferrara C; Matalon R; Strisciuglio P
Eur J Clin Nutr; 2017 Jan; 71(1):51-55. PubMed ID: 27623981
[TBL] [Abstract][Full Text] [Related]
17. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
Matalon R; Michals-Matalon K; Bhatia G; Burlina AB; Burlina AP; Braga C; Fiori L; Giovannini M; Grechanina E; Novikov P; Grady J; Tyring SK; Guttler F
J Inherit Metab Dis; 2007 Apr; 30(2):153-8. PubMed ID: 17334706
[TBL] [Abstract][Full Text] [Related]
18. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
20. Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.
Yano S; Moseley K; Azen C
J Pediatr; 2014 Jul; 165(1):184-189.e1. PubMed ID: 24857519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
